Literature DB >> 17400334

Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.

Davis Ryman1, Yuan Gao, Bruce T Lamb.   

Abstract

Genetic studies have demonstrated very high heritability for Alzheimer's disease (AD) risk in humans; however, these genetic contributions have proven extremely challenging to map in large studies of AD patients. Processing of the amyloid precursor protein (APP) to produce amyloid-beta (Abeta) peptide is increasingly believed to be of central importance in AD pathogenesis. Intriguingly, mice from the C57BL/6J and DBA2/J inbred strains carrying the R1.40 APP transgene produce identical levels of unprocessed APP, but demonstrate significant, heritable differences in Abeta levels. To identify specific loci responsible for the observed genetic control of Abeta metabolism in this model system, we have performed a whole-genome quantitative trait locus (QTL) mapping experiment on a total of 516 animals from a C57BL/6JxDBA/2J intercross using a dense set of SNP genetic markers. Our studies have identified three loci on mouse chromosomes 1, 2, and 7 showing significant or suggestive associations with brain Abeta levels, several of which contain regions syntenic to previous reports of linkage in human AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400334      PMCID: PMC3745768          DOI: 10.1016/j.neurobiolaging.2007.02.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  39 in total

1.  APOE and AD concordance in twin pairs as predictors of AD in first-degree relatives.

Authors:  D C Steffens; B L Plassman; M J Helms; K A Welsh-Bohmer; T T Newman; J C Breitner
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

2.  Results of a high-resolution genome screen of 437 Alzheimer's disease families.

Authors:  Deborah Blacker; Lars Bertram; Aleister J Saunders; Thomas J Moscarillo; Marilyn S Albert; Howard Wiener; Rodney T Perry; Julianne S Collins; Lindy E Harrell; Rodney C P Go; Amy Mahoney; Terri Beaty; M Danielle Fallin; Dimitrios Avramopoulos; Gary A Chase; Marshal F Folstein; Melvin G McInnis; Susan S Bassett; Kimberly J Doheny; Elizabeth W Pugh; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2003-01-01       Impact factor: 6.150

3.  The number of trait loci in late-onset Alzheimer disease.

Authors:  E W Daw; H Payami; E J Nemens; D Nochlin; T D Bird; G D Schellenberg; E M Wijsman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

4.  Identification of novel genes in late-onset Alzheimer's disease.

Authors:  M A Pericak-Vance; J Grubber; L R Bailey; D Hedges; S West; L Santoro; B Kemmerer; J L Hall; A M Saunders; A D Roses; G W Small; W K Scott; P M Conneally; J M Vance; J L Haines
Journal:  Exp Gerontol       Date:  2000-12       Impact factor: 4.032

5.  Full genome screen for Alzheimer disease: stage II analysis.

Authors:  Amanda Myers; Fabienne Wavrant De-Vrieze; Peter Holmans; Marian Hamshere; Richard Crook; Danielle Compton; Helen Marshall; David Meyer; Shantia Shears; Jeremy Booth; Dzanan Ramic; Heather Knowles; John C Morris; Nigel Williams; Nadine Norton; Richard Abraham; Pat Kehoe; Hywel Williams; Varuni Rudrasingham; Francis Rice; Peter Giles; Nigel Tunstall; Lesley Jones; Simon Lovestone; Julie Williams; Michael J Owen; John Hardy; Alison Goate
Journal:  Am J Med Genet       Date:  2002-03-08

6.  Age at onset in two common neurodegenerative diseases is genetically controlled.

Authors:  Yi-Ju Li; William K Scott; Dale J Hedges; Fengyu Zhang; P Craig Gaskell; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; Fred A Allen; Christopher G Goetz; Frank Mastaglia; Jeffrey M Stajich; Rachel A Gibson; Lefkos T Middleton; Ann M Saunders; Burton L Scott; Gary W Small; Kristin K Nicodemus; Allison D Reed; Donald E Schmechel; Kathleen A Welsh-Bohmer; P Michael Conneally; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

7.  Complement C1q expression induced by Abeta in rat hippocampal organotypic slice cultures.

Authors:  Rong Fan; Andrea J Tenner
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

8.  Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.

Authors:  Emily J H Lehman; Laura Shapiro Kulnane; Yuan Gao; Michelle C Petriello; Karen M Pimpis; Linda Younkin; Georgia Dolios; Rong Wang; Steven G Younkin; Bruce T Lamb
Journal:  Hum Mol Genet       Date:  2003-09-23       Impact factor: 6.150

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Genetic modulation of tau phosphorylation in the mouse.

Authors:  Jochen Brich; Feng-Shiun Shie; Brian W Howell; Renhua Li; Katalin Tus; Edward K Wakeland; Lee-Way Jin; Marc Mumby; Gary Churchill; Joachim Herz; Jonathan A Cooper
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

View more
  19 in total

Review 1.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

2.  Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease.

Authors:  Maria I Fonseca; Rahasson R Ager; Shu-Hui Chu; Ozkan Yazan; Sam D Sanderson; Frank M LaFerla; Stephen M Taylor; Trent M Woodruff; Andrea J Tenner
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

3.  Genes of susceptibility to early neurodegenerative changes in the rat retina and brain: analysis by means of congenic strains.

Authors:  Elena E Korbolina; Anna A Zhdankina; Anzhela Zh Fursova; Oyuna S Kozhevnikova; Natalia G Kolosova
Journal:  BMC Genet       Date:  2016-12-22       Impact factor: 2.797

Review 4.  Complement in the brain.

Authors:  Robert Veerhuis; Henrietta M Nielsen; Andrea J Tenner
Journal:  Mol Immunol       Date:  2011-05-04       Impact factor: 4.407

5.  Teaching bioinformatics and neuroinformatics by using free web-based tools.

Authors:  William Grisham; Natalie A Schottler; Joanne Valli-Marill; Lisa Beck; Jackson Beatty
Journal:  CBE Life Sci Educ       Date:  2010       Impact factor: 3.325

Review 6.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12

7.  Transcriptome analysis of distinct mouse strains reveals kinesin light chain-1 splicing as an amyloid-β accumulation modifier.

Authors:  Takashi Morihara; Noriyuki Hayashi; Mikiko Yokokoji; Hiroyasu Akatsu; Michael A Silverman; Nobuyuki Kimura; Masahiro Sato; Yuhki Saito; Toshiharu Suzuki; Kanta Yanagida; Takashi S Kodama; Toshihisa Tanaka; Masayasu Okochi; Shinji Tagami; Hiroaki Kazui; Takashi Kudo; Ryota Hashimoto; Naohiro Itoh; Kouhei Nishitomi; Yumi Yamaguchi-Kabata; Tatsuhiko Tsunoda; Hironori Takamura; Taiichi Katayama; Ryo Kimura; Kouzin Kamino; Yoshio Hashizume; Masatoshi Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-04       Impact factor: 11.205

8.  Harnessing Genetic Complexity to Enhance Translatability of Alzheimer's Disease Mouse Models: A Path toward Precision Medicine.

Authors:  Sarah M Neuner; Sarah E Heuer; Matthew J Huentelman; Kristen M S O'Connell; Catherine C Kaczorowski
Journal:  Neuron       Date:  2018-12-27       Impact factor: 17.173

9.  Prion protein and Abeta-related synaptic toxicity impairment.

Authors:  Anna Maria Calella; Mélissa Farinelli; Mario Nuvolone; Osvaldo Mirante; Rita Moos; Jeppe Falsig; Isabelle M Mansuy; Adriano Aguzzi
Journal:  EMBO Mol Med       Date:  2010-08       Impact factor: 12.137

10.  Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.

Authors:  Zuzana Stozicka; Norbert Zilka; Petr Novak; Branislav Kovacech; Ondrej Bugos; Michal Novak
Journal:  J Neuroinflammation       Date:  2010-10-12       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.